Talis BiomedicalTLIS
TLIS
Delisted
TLIS was delisted on the 3rd of September, 2024.
About: Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Employees: 99
Financial journalist opinion
Charts implemented using Lightweight Charts™